Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
PPG Industries
PPG
$25.3B
| $83.9M | 0.16% |
731,570
+66,336
| +10% | +$7.58M |
|
|
GPOR
127
DELISTED
Gulfport Energy Corp.
GPOR
| $83.5M | 0.16% |
2,074,192
-1,359,541
| -40% | -$62.3M |
|
128
Boston Properties
BXP
$10.8B
| $83.4M | 0.16% |
688,743
+328,231
| +91% | +$43.2M |
|
|
GG
129
DELISTED
Goldcorp Inc
GG
| $82.5M | 0.16% |
5,094,477
+4,664,977
| +1,086% | +$85M |
|
130
Elevance Health
ELV
$86.9B
| $80.7M | 0.15% |
+491,675
| New | +$78.6M |
|
131
Delek US
DK
$4.38B
| $80.1M | 0.15% |
2,175,368
+1,537,214
| +241% | +$57.7M |
|
|
GGP
132
DELISTED
GGP Inc.
GGP
| $79.6M | 0.15% |
3,103,688
-2,675,572
| -46% | -$74.6M |
|
133
Designer Brands
DBI
$292M
| $79.6M | 0.15% |
2,384,789
+317,931
| +15% | +$11.4M |
|
134
Gilead Sciences
GILD
$181B
| $79.3M | 0.15% |
677,283
-294,652
| -30% | -$32.2M |
|
135
Invesco
IVZ
$14.1B
| $78.9M | 0.15% |
2,105,338
-112,660
| -5% | -$4.51M |
|
|
MWE
136
CALL
DELISTED
MARKWEST ENERGY PARTNERS, LP
MWE
| $78.8M | 0.15% |
1,397,300
+296,100
| +27% | +$19.1M |
|
137
RenaissanceRe
RNR
$13.4B
| $78.6M | 0.15% |
774,208
+55,631
| +8% | +$5.73M |
|
138
Mohawk Industries
MHK
$9.23B
| $78.5M | 0.15% |
410,974
-11,671
| -3% | -$2.16M |
|
|
ALDR
139
DELISTED
Alder Biopharmaceuticals
ALDR
| $78M | 0.15% |
1,472,425
+985,135
| +202% | +$35.8M |
|
|
SEMG
140
DELISTED
SEMGROUP CORPORATION
SEMG
| $77.6M | 0.15% |
976,955
-139,049
| -12% | -$11.3M |
|
141
Microsoft
MSFT
$3.59T
| $77.6M | 0.15% |
1,757,563
+870,362
| +98% | +$39.7M |
|
142
Boston Scientific
BSX
$73B
| $77.6M | 0.15% |
4,381,618
+481,922
| +12% | +$8.61M |
|
143
AerCap
AER
$23B
| $77.5M | 0.15% |
1,692,944
+1,642,944
| +3,286% | +$77.9M |
|
|
CY
144
DELISTED
Cypress Semiconductor
CY
| $77M | 0.15% |
6,551,274
-966,187
| -13% | -$12.7M |
|
145
Lowe's Companies
LOW
$121B
| $76.8M | 0.15% |
1,146,035
+849,526
| +287% | +$60.6M |
|
146
Amgen
AMGN
$238B
| $76.6M | 0.14% |
498,789
+285,474
| +134% | +$45.7M |
|
|
ETP
147
CALL
DELISTED
Energy Transfer Partners L.p.
ETP
| $76.5M | 0.14% |
1,466,400
+621,600
| +74% | +$34.7M |
|
|
AMAG
148
DELISTED
AMAG Pharmaceuticals
AMAG
| $75.7M | 0.14% |
1,096,638
+187,433
| +21% | +$11.8M |
|
|
MIC
149
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $75.3M | 0.14% |
911,205
+161,998
| +22% | +$13.7M |
|
150
Essex Property Trust
ESS
$18.6B
| $75.2M | 0.14% |
354,089
+114,502
| +48% | +$25.3M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.